English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 24 January 2020, 12:00 HKT/SGT
Share:
New Disinfectant Stops Spread of Virus, Including Coronavirus Strain from China

SYDNEY, AU, Jan 24, 2020 - (ACN Newswire) - Australian researcher Steven Kritzler says his Evocide Extra disinfectant is able to stop the spread of virus, as in the present outbreak in Wuhan City, China. This new strain of Coronavirus is a SARS-like virus that has caused hundreds of infections in China, and has spread to Thailand, Japan and South Korea.

Steven Kritzler of Novapharm Research (Aus) Pty. Ltd.

"Both the Wuhan virus, known as 2019-nCoV, and SARS belong to the family of viruses known as Coronaviridae, which can be deactivated by many materials, such as Evocide Extra," says Kritzler, who is based at Novapharm Research near Sydney, and is a committee member of the Australian Therapeutic Goods Administration (TGA).

Kritzler garnered attention at the Symposium on Advanced Infection Control in November when his Evocide Extra disinfectant formulation was presented. "Coronavirus is a type of enveloped virus -- a virus that develops viruses. My formulation can deactivate any virus, including enveloped and non-enveloped viruses."

"Coronavirus is microscopic, hence face masks alone cannot effectively prevent spreading the virus. I suggest that the best way to protect from spreading the virus is to wash your hands regularly, for example when you touch the door handle. And remember to use the disinfectants in time," says Kritzler.

Southern Cross, another formulation by Kritzler, are eco-friendly skin and hard surface disinfectant paper wipes that can deactivate viruses such as HIV (human immunodeficiency virus), hand-foot-mouth (EV71), influenza A (H1N1) and measles, and like Evocide can kill 99.999% of bacterial pathogens including super bacteria.

The Chinese Spring Festival holiday begins later this week, increasing the risk of spread of the new virus. The holiday period typically sees hundreds of millions of Chinese traveling throughout the country and overseas.

Contact: Kenny Kang, kz@fromau.com
Southern Cross Biotechnology Pty Ltd.

Topic: Press release summary Sectors: Environment, ESG, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance  
Aug 14, 2025 21:22 HKT/SGT
The 35th Food Expo opens today  
Aug 14, 2025 20:05 HKT/SGT
Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million  
Aug 14, 2025 19:15 HKT/SGT
Formerra Becomes North American Distributor for Syensqo PVDF  
Aug 14, 2025 17:34 HKT/SGT
China Lilang Announces 2025 Interim Results  
Aug 14, 2025 17:32 HKT/SGT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products  
Aug 14, 2025 17:32 HKT/SGT
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row  
Aug 14, 2025 17:31 HKT/SGT
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration  
Aug 14, 2025 17:17 HKT/SGT
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access  
Aug 14, 2025 17:12 HKT/SGT
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth  
Aug 14, 2025 15:27 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575